Global Asset Allocation Fund
Mutual Fund | Multi-Asset Class
Overview
The GMO Global Asset Allocation Fund seeks to achieve a total return greater than that of its benchmark of 65% MSCI All Country World Index and 35% Bloomberg U.S. Aggregate Index by allocating dynamically across asset classes.
The philosophy that underlies all of GMO’s Asset Allocation investment strategies is the belief that, at times and in the short term, the pricing of asset classes can deviate from true intrinsic value, but mean reverts to appropriate valuation levels over a complete market cycle. GMO’s proprietary 7-Year Asset Class Forecasts form the foundation of our investment process, providing a framework to assess the return opportunity embedded in different asset classes. We use that insight to allocate to what we believe are the most attractively priced asset classes. We also seek to add value through security selection within both traditional and alternative asset classes.
Facts
Fund Inception Date | June 28, 1996 |
CUSIP | 362007171 |
Benchmark | GMO Global Asset Allocation Index |
Fund Total Assets as of 12/31/2024 | $364mm USD |
Share Class R6
Inception Date | September 30, 2019 |
Ticker Symbol | GMWRX |
CUSIP | 362014359 |
NAV as of 1/17/2025 | 32.16 |
Net Expense Ratio 1 | 0.69 |
Gross Expense Ratio 2 | 0.74 |
Adjusted Expense Ratio 3 | 0.58 |
1 Net Expense Ratio reflects the reduction of expenses from fee reimbursements. The fee reimbursements will continue until at least June 30, 2025. Elimination of this reimbursement will result in higher fees and lower performance.
2 Gross Expense Ratio is equal to the Funds Total Annual Operating Expenses set forth in the Funds most recent prospectus dated June 30, 2024.
3 Adjusted expense ratio excludes certain investment-related costs, such as dividend and interest expense on short sales and interest expense incurred through entering into reverse repurchase agreements. The total of these costs, where applicable, can be found in the most recent prospectus.
Performance
Quarter-End as of December 31, 2024(USD, %) | Global Asset Alloc. Fund-R6
1-Year | 3-Year | 5-Year | |
---|---|---|---|
Global Asset Allocation Fund | 5.13 | 2.16 | 3.89 |
GMO Global Asset Allocation Index | 11.60 | 2.77 | 6.57 |
- Global Asset Allocation Fund 1
- GMO Global Asset Allocation Index
Inception Date: September 30, 2019
Returns shown for periods greater than one year are on an annualized basis.
If certain expenses were not reimbursed, performance would be lower. Transaction costs, if any, are paid to the fund to offset the cost of portfolio transactions to invest or raise cash.
Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.
1 Returns include a substantial, one-time litigation settlement recovery received on December 16, 2024. This event contributed 0.73% to Q4 2024 and 0.80% to 2024 annual performance. Performance for other periods, including this date, was also positively impacted, sometimes materially. Without this recovery, performance would have been lower in both absolute terms and relative to the benchmark. Additional information is available upon request.
Quarter-End as of December 31, 2024(USD, %) | Global Asset Alloc. Fund-R6
QTD | YTD | 1-Year | 3-Year | 5-Year | |
---|---|---|---|---|---|
Global Asset Allocation Fund | -4.23 | 5.13 | 5.13 | 2.16 | 3.89 |
GMO Global Asset Allocation Index | -1.71 | 11.60 | 11.60 | 2.77 | 6.57 |
- Global Asset Allocation Fund 1
- GMO Global Asset Allocation Index
Inception Date: September 30, 2019
Returns shown for periods greater than one year are on an annualized basis.
Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.
Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.
1 Returns include a substantial, one-time litigation settlement recovery received on December 16, 2024. This event contributed 0.73% to Q4 2024 and 0.80% to 2024 annual performance. Performance for other periods, including this date, was also positively impacted, sometimes materially. Without this recovery, performance would have been lower in both absolute terms and relative to the benchmark. Additional information is available upon request.
Quarter-End as of December 31, 2024(USD, %) | Global Asset Alloc. Fund-R6
QTD | YTD | 1-Year | 3-Year | 5-Year | |
---|---|---|---|---|---|
Global Asset Allocation Fund | -4.09 | 5.74 | 5.74 | 2.74 | 4.48 |
GMO Global Asset Allocation Index | -1.71 | 11.60 | 11.60 | 2.77 | 6.57 |
- Global Asset Allocation Fund 1
- GMO Global Asset Allocation Index
Inception Date: September 30, 2019
Returns shown for periods greater than one year are on an annualized basis.
Gross of fees, expenses and transaction costs, if any. If these fees, expenses and costs were included, performance would be lower.
Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.
1 Returns include a substantial, one-time litigation settlement recovery received on December 16, 2024. This event contributed 0.73% to Q4 2024 and 0.80% to 2024 annual performance. Performance for other periods, including this date, was also positively impacted, sometimes materially. Without this recovery, performance would have been lower in both absolute terms and relative to the benchmark. Additional information is available upon request.
Month-End as of December 31, 2024(USD, %) | Global Asset Alloc. Fund-R6
MTD | QTD | YTD | 1-Year | 3-Year | 5-Year | |
---|---|---|---|---|---|---|
Global Asset Allocation Fund | -1.84 | -4.23 | 5.13 | 5.13 | 2.16 | 3.89 |
GMO Global Asset Allocation Index | -2.11 | -1.71 | 11.60 | 11.60 | 2.77 | 6.57 |
- Global Asset Allocation Fund 1
- GMO Global Asset Allocation Index
Inception Date: September 30, 2019
Returns shown for periods greater than one year are on an annualized basis.
Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.
Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.
1 Returns include a substantial, one-time litigation settlement recovery received on December 16, 2024. This event contributed 0.73% to Q4 2024 and 0.80% to 2024 annual performance. Performance for other periods, including this date, was also positively impacted, sometimes materially. Without this recovery, performance would have been lower in both absolute terms and relative to the benchmark. Additional information is available upon request.
Month-End as of December 31, 2024(USD, %) | Global Asset Alloc. Fund-R6
MTD | QTD | YTD | 1-Year | 3-Year | 5-Year | |
---|---|---|---|---|---|---|
Global Asset Allocation Fund | -1.79 | -4.09 | 5.74 | 5.74 | 2.74 | 4.48 |
GMO Global Asset Allocation Index | -2.11 | -1.71 | 11.60 | 11.60 | 2.77 | 6.57 |
- Global Asset Allocation Fund 1
- GMO Global Asset Allocation Index
Inception Date: September 30, 2019
Returns shown for periods greater than one year are on an annualized basis.
Gross of fees, expenses and transaction costs, if any. If these fees, expenses and costs were included, performance would be lower.
Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.
1 Returns include a substantial, one-time litigation settlement recovery received on December 16, 2024. This event contributed 0.73% to Q4 2024 and 0.80% to 2024 annual performance. Performance for other periods, including this date, was also positively impacted, sometimes materially. Without this recovery, performance would have been lower in both absolute terms and relative to the benchmark. Additional information is available upon request.
Year Ending December 31 (USD, %) | Global Asset Alloc. Fund-R6
Global Asset Allocation Fund | GMO Global Asset Allocation Index | |
---|---|---|
2024 | 5.13 | 11.60 |
2023 | 16.15 | 16.21 |
2022 | -12.69 | -16.30 |
2021 | 6.97 | 11.22 |
2020 | 6.14 | 13.90 |
2019 | 6.55 | 5.83 |
- Global Asset Allocation Fund 1
- GMO Global Asset Allocation Index
Inception Date: September 30, 2019
Returns shown for periods greater than one year are on an annualized basis.
Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.
Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.
1 Returns include a substantial, one-time litigation settlement recovery received on December 16, 2024. This event contributed 0.73% to Q4 2024 and 0.80% to 2024 annual performance. Performance for other periods, including this date, was also positively impacted, sometimes materially. Without this recovery, performance would have been lower in both absolute terms and relative to the benchmark. Additional information is available upon request.
Year Ending December 31 (USD, %) | Global Asset Alloc. Fund-R6
Global Asset Allocation Fund | GMO Global Asset Allocation Index | |
---|---|---|
2024 | 5.74 | 11.60 |
2023 | 16.80 | 16.21 |
2022 | -12.19 | -16.30 |
2021 | 7.59 | 11.22 |
2020 | 6.73 | 13.90 |
2019 | 6.70 | 5.83 |
- Global Asset Allocation Fund 1
- GMO Global Asset Allocation Index
Inception Date: September 30, 2019
Returns shown for periods greater than one year are on an annualized basis.
Gross of fees, expenses and transaction costs, if any. If these fees, expenses and costs were included, performance would be lower.
Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.
1 Returns include a substantial, one-time litigation settlement recovery received on December 16, 2024. This event contributed 0.73% to Q4 2024 and 0.80% to 2024 annual performance. Performance for other periods, including this date, was also positively impacted, sometimes materially. Without this recovery, performance would have been lower in both absolute terms and relative to the benchmark. Additional information is available upon request.
Documents
Literature
Downloads
Commentary & Attribution
Risks
Risks associated with investing in the Fund may include: (1) Market Risk - Equities: The market price of equities may decline due to factors affecting the issuer, its industries, or the economy and equity markets generally. Declines in stock market prices generally are likely to reduce the net asset value of the Fund's shares. (2) Management and Operational Risk: The risk that GMO's investment techniques will fail to produce desired results, including annualized returns and annualized volatility. (3) Non-U.S. Investment Risk: The market prices of many non-U.S. securities (particularly of companies tied economically to emerging countries) fluctuate more than those of U.S. securities. Many non-U.S. markets (particularly emerging markets) are less stable, smaller, less liquid, and less regulated than U.S. markets, and the cost of trading in those markets often is higher than it is in U.S. markets.For a more complete discussion of these risks and others, please consult the Fund's Prospectus.
Disclosures
An investor should consider the fund’s investment objectives, risks, charges and expenses before investing. This and other important information can be found in the fund’s prospectus. Read the prospectus carefully before investing. Please see prospectus above.
The GMO Trust funds are distributed in the United States by Funds Distributor LLC. GMO and Funds Distributor LLC are not affiliated.